Literature DB >> 2412742

Ability of isoprinosine to restore interleukin-2 production and T cell proliferation in autoimmune mice.

M Fischbach, N Talal.   

Abstract

Autoimmune mice bearing the single autosomal recessive gene 1pr are unable to produce the T cell growth factor, interleukin-2 (IL-2). A physiological consequence of this defect is the inability of T cells from C57B1/6J-lpr/lpr mice to respond to antigen presented by macrophages. In an attempt to reverse these abnormalities, we administered the inosine containing drug isoprinosine. Injection of isoprinosine after antigen immunization restored both antigen presentation and IL-2 production.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412742      PMCID: PMC1577290     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

Review 1.  Immunologic and viral factors in autoimmune diseases.

Authors:  N Talal
Journal:  Med Clin North Am       Date:  1977-03       Impact factor: 5.456

2.  Suppressor cell activity after isoprinosine treatment of lymphocytes from normal mice.

Authors:  G Renoux; M Renoux; D Degenne
Journal:  Int J Immunopharmacol       Date:  1979

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  The autologous mixed lymphocyte reaction in strains of mice with autoimmune disease.

Authors:  L H Glimcher; A D Steinberg; S B House; I Green
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

5.  Antigen-induced proliferation assay for mouse T lymphocytes. Response to a monovalent antigen.

Authors:  S S Alkan
Journal:  Eur J Immunol       Date:  1978-02       Impact factor: 5.532

6.  Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation.

Authors:  J W Hadden; E M Hadden; R G Coffey
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

7.  The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies.

Authors:  E L Reinherz; C O'Brien; P Rosenthal; S F Schlossman
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

8.  Ability of NZW but not NZB antigen-presenting cells to support T cell proliferative response to DNA methylated albumin.

Authors:  R Papoian; N Talal
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

9.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition.

Authors:  D D Eardley; J Hugenberger; L McVay-Boudreau; F W Shen; R K Gershon; H Cantor
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  2 in total

Review 1.  New therapeutic approaches to autoimmune disease.

Authors:  N Talal
Journal:  Springer Semin Immunopathol       Date:  1986

2.  A placebo-controlled trial of isoprinosine in patients with multiple sclerosis.

Authors:  N M Milligan; D H Miller; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.